ArticleMolecules (Basel, Switzerland)2023

Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers.

Kinga Żelechowska-Matysiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.